DENTSPLY SIRONA Inc.

NasdaqGS:XRAY Rapporto sulle azioni

Cap. di mercato: US$4.8b

DENTSPLY SIRONA Gestione

Gestione criteri di controllo 2/4

DENTSPLY SIRONA's CEO is Simon Campion, appointed in Sep 2022, has a tenure of 2.17 years. total yearly compensation is $8.52M, comprised of 11.7% salary and 88.3% bonuses, including company stock and options. directly owns 0.089% of the company’s shares, worth $4.24M. The average tenure of the management team and the board of directors is 1.5 years and 4.7 years respectively.

Informazioni chiave

Simon Campion

Amministratore delegato

US$8.5m

Compenso totale

Percentuale dello stipendio del CEO11.7%
Mandato del CEO2.2yrs
Proprietà del CEO0.09%
Durata media del management1.5yrs
Durata media del Consiglio di amministrazione4.7yrs

Aggiornamenti recenti sulla gestione

Recent updates

DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

Oct 13
DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 25
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough

Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Sep 05
Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?

Aug 18
Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes

Jul 11
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes

A Tough Macro Environment Makes Dentsply Sirona's Turnaround Even Harder

Jul 02

Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price

Jun 11
Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

May 24
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Dentsply Sirona: I'm Buying The Pullback In This Medtech Leader

Apr 24

Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

Apr 22
Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Mar 10
There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

Feb 16
Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

Jan 29
DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Jan 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Nov 25
Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Nov 06
These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

Oct 15
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

Sep 18
An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

Jul 31
DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Jul 09
The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Jun 20
A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Jun 02
When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

May 15
Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Apr 05
The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

Mar 07
Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Nov 09
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Dentsply Sirona names Glenn Coleman as new CFO

Sep 22

Dentsply Sirona hires Simon Campion as president, CEO

Aug 25

Dentsply Sirona receives noncompliance notice from Nasdaq

Aug 16

Dentsply Sirona: Weakening Fundamentals Outweigh 'Defensives' Argument

Jul 18

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Simon Campion rispetto agli utili di DENTSPLY SIRONA?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

-US$185m

Mar 31 2024n/an/a

-US$95m

Dec 31 2023US$9mUS$1m

-US$132m

Sep 30 2023n/an/a

-US$214m

Jun 30 2023n/an/a

-US$1b

Mar 31 2023n/an/a

-US$1b

Dec 31 2022US$8mUS$304k

-US$950m

Compensazione vs Mercato: Simon's total compensation ($USD8.52M) is about average for companies of similar size in the US market ($USD6.66M).

Compensazione vs guadagni: Simon's compensation has increased whilst the company is unprofitable.

AMMINISTRATORE DELEGATO

Simon Campion (52 yo)

2.2yrs

Mandato

US$8,518,987

Compensazione

Mr. Simon D. Campion serves as Chief Executive Officer at DENTSPLY SIRONA Inc. since September 12, 2022 and also serves as its President & Director since September 2022. He served as an Executive Vice Pres...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Simon Campion
CEO, President & Director2.2yrsUS$8.52m0.089%
$ 4.2m
Glenn Coleman
Executive VP & CFO2.2yrsUS$3.90m0.013%
$ 605.2k
Richard Rosenzweig
Executive VP of Corporate Development1.8yrsUS$4.35m0.0052%
$ 248.6k
Robert Johnson
Senior VP & Chief Supply Chain Officer and Head of Sustainabilityless than a yearUS$2.94m0.010%
$ 481.9k
Kevin Boyle
Senior VP & Chief Technology Officerless than a yearNessun datoNessun dato
Andrea Daley
Vice President of Investor Relationsno dataNessun datoNessun dato
Andrea Frohning
Senior VP & Chief Human Resources Officer1.3yrsNessun dato0.00090%
$ 42.9k
Emily Miner
Senior VP of Global Quality and Regulatory & Chief Quality Officer1.5yrsNessun datoNessun dato
Dan Workinger
Treasurerno dataNessun datoNessun dato
Dane Baumgardner
Attorney-In-Factno dataNessun datoNessun dato
Gerard Campbell
Group Vice President for EMEA RCOno dataNessun datoNessun dato
Bruce Peatey
Group Vice President for APAC RCOno dataNessun datoNessun dato

1.5yrs

Durata media

55yo

Età media

Gestione esperta: XRAY's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Simon Campion
CEO, President & Director2.2yrsUS$8.52m0.089%
$ 4.2m
Clyde Hosein
Independent Director4.2yrsUS$300.00k0.0090%
$ 429.5k
Betsy Holden
Independent Director6.8yrsUS$315.00k0.0013%
$ 63.8k
Leslie Varon
Independent Director6.8yrsUS$325.00k0.013%
$ 600.5k
Brian Gladden
Independent Directorless than a yearUS$25.00kNessun dato
Gregory Lucier
Independent Chairman5.5yrsUS$318.75k0.035%
$ 1.6m
William Deese
Independent Director13.8yrsUS$320.00k0.017%
$ 824.3k
Janet Vergis
Independent Director5.2yrsUS$315.00k0.011%
$ 513.3k
Ilse Wenzel
Independent Director2.8yrsUS$310.00k0.0041%
$ 197.1k
Jonathan Mazelsky
Independent Director1.5yrsUS$260.44k0.0027%
$ 129.5k

4.7yrs

Durata media

61.5yo

Età media

Consiglio di amministrazione esperto: XRAY's board of directors are considered experienced (4.7 years average tenure).